4-Chloro-2-(methoxymethyl)-6-methylpyrimidine

Catalog No.: 
ACAZSO167
CAS No.: 
3122-80-3
Molecular Formula: 
C7H9ClN2O
Molecular Weight: 
172.62
4-Chloro-2-(methoxymethyl)-6-methylpyrimidine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$67.00In stockInquiry
1g95%$180.00In stockInquiry
5g95%$422.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-Chloro-2-(methoxymethyl)-6-methylpyrimidine
IUPAC Name4-chloro-2-(methoxymethyl)-6-methylpyrimidine
MDL No.MFCD11043806
Molecular FormulaC7H9ClN2O
Molecular Weight172.62
SMILESCC1=CC(Cl)=NC(COC)=N1
InChI KeyLRAIBXGPDUQUBD-UHFFFAOYSA-N
Synonym4-CHLORO-2-METHOXYMETHYL-6-METHYLPYRIMIDINE;Pyrimidine, 4-chloro-2-(methoxymethyl)-6-methyl-
CAS No.3122-80-3
PubChem CID13153422

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACAZSO167 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACAZSO167 route product structure diagram
    ACAZSO1673122-80-3In Stock
Inquiry

2. ACAZSO167 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACAZSO167 route product structure diagram
    ACAZSO1673122-80-3In Stock
Inquiry

3. ACAZSO167 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACAZSO167 route product structure diagram
    ACAZSO1673122-80-3In Stock
Inquiry

Comments (0)